Chuah S Y, Leong C K, Pang C W
Hospital Pantai, Ayer Keroh 2418-1, km 8, Lebuh Ayer Keroh, 75450 Melaka, Malaysia.
Singapore Med J. 2003 May;44(5):261-7.
Opium addicts (OA) with no biliary symptoms have been shown to have dilated common bile duct (CBD). Endoscopic retrograde cholangio-pancreatography (ERCP) without biliary drainage in such asymptomatic OA is hazardous. Hence it is not indicated unless there are clear clinical and laboratory evidences of biliary stasis.
To show that even when matched with controls with the same clinical diagnosis of the biliary system, OA still have significantly larger CBD diameters and that OA with biliary symptoms should be treated no differently from non-OA with biliary symptoms.
Seven OA (all Chinese males), four of whom had undergone ERCP (three for CBD stones and one for ampullary carcinoma), were compared, using t-test, to 7 age, sex, race and diagnosis-matched controls, four of whom had also undergone ERCP (three for CBD stones and one for ampullary carcinoma). When ERCP was not done, ultrasonography was used to assess the biliary system and measure the CBD diameter.
The mean (SD) CBD diameters of OA and controls were 15.7 mm (5.65) and 8.3 mm (5.95) respectively (t = 2.399, p = 0.032). The mean (SD) weight of OA and controls were 55.8 kg (9.22) and 57.3 kg (9.21) respectively (t = -0.305, p = 0.763). Only two of the seven OA were born in China, the remaining five in Malaysia.
OA do get CBD pathology like non-OA and if indicated there should be no qualms about performing ERCP in them. When matched for age, sex, race and clinical diagnosis, OA still have a significantly larger CBD despite no difference in body weight.
已证实无胆道症状的鸦片成瘾者(OA)存在胆总管(CBD)扩张。在此类无症状OA患者中,未进行胆道引流的内镜逆行胰胆管造影(ERCP)具有危险性。因此,除非有明确的临床和实验室证据表明存在胆道淤滞,否则不建议进行该检查。
旨在表明,即使与具有相同胆道系统临床诊断的对照组相匹配,OA患者的CBD直径仍显著更大,且有胆道症状的OA患者应与无胆道症状的非OA患者接受相同的治疗。
采用t检验,将7例OA患者(均为中国男性)与7例年龄、性别、种族和诊断相匹配的对照组进行比较,其中4例OA患者和4例对照组患者均接受了ERCP(3例OA患者因CBD结石接受ERCP,1例因壶腹癌接受ERCP;3例对照组患者因CBD结石接受ERCP,1例因壶腹癌接受ERCP)。未进行ERCP时,采用超声检查评估胆道系统并测量CBD直径。
OA患者和对照组的CBD平均(标准差)直径分别为15.7 mm(5.65)和8.3 mm(5.95)(t = 2.399,p = 0.032)。OA患者和对照组的平均(标准差)体重分别为55.8 kg(9.22)和57.3 kg(9.21)(t = -0.305,p = 0.763)。7例OA患者中只有2例出生于中国,其余5例出生于马来西亚。
OA患者与非OA患者一样会出现CBD病变,如有指征,对他们进行ERCP检查无需顾虑。在年龄、性别、种族和临床诊断相匹配的情况下,尽管体重无差异,但OA患者的CBD仍显著更大。